PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis

Pierpaolo Biondetti1, Mark G Vangel2, Rita M Lahoud1

  • 1Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, White 270, Boston, MA, 02114, USA.

Abstract

Insights

Positron emission tomography/magnetic resonance (PET/MR) has lower sensitivity for detecting lung nodules compared to standard chest imaging. While some missed nodules grew, they did not impact clinical management in patients with primary abdominal malignancies.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Lung nodules are common incidental findings in patients undergoing imaging for primary abdominal malignancies.
  • Accurate detection and characterization of lung nodules are crucial for staging and management.
  • Positron emission tomography/magnetic resonance (PET/MR) is an emerging imaging modality with potential advantages, but its performance in lung nodule detection needs evaluation.

Purpose of the Study:

  • To compare the efficacy of PET/MR in detecting lung nodules versus standard of care imaging (SCI) such as PET/CT or CT.
  • To assess the growth of lung nodules that were missed by PET/MR.
  • To investigate the clinical management implications of lung nodules missed by PET/MR in patients with primary abdominal malignancies.

Main Methods:

  • A retrospective study included 126 patients who underwent [18F]-FDG PET/MR.
  • Standard of care chest imaging (CT or PET/CT) within 6 weeks served as the reference standard.
  • Two radiologists independently assessed lung nodules on both PET/MR and SCI, with follow-up imaging used to evaluate growth of missed nodules.

Main Results:

  • A total of 505 nodules were detected by SCI, while PET/MR detected only 61 nodules, resulting in a sensitivity of 12.1% for nodules.
  • PET/MR sensitivity was higher for larger nodules (>7 mm).
  • Of the nodules missed by PET/MR, 22.3% showed growth on follow-up, but this did not alter patient management in this cohort.

Conclusions:

  • PET/MR demonstrates lower sensitivity for lung nodule detection compared to standard chest imaging, influenced by nodule size.
  • A significant proportion of nodules missed by PET/MR exhibited growth, suggesting potential metastatic disease.
  • While missed nodules did not impact management in this study group, implications may differ in patients without advanced extra-thoracic disease.